Specifically, up to 70% of LGG and 90% of secondary upgraded GBM harbor a heterozygous missense mutation in one copy of the gene encoding for the isocitrate dehydrogenase 1 (IDH1) enzyme, and this mutation is now recognized as an essential driver of LGG development11–13. This evidence concerns the gene IDH1 and glioblastoma.